1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial
Top Cited Papers
- 1 February 2003
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 361 (9358) , 662-668
- https://doi.org/10.1016/s0140-6736(03)12600-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A meta‐analysis comparing buprenorphine to methadone for treatment of opiate dependenceAddiction, 2001
- A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid DependenceNew England Journal of Medicine, 2000
- Effective Medical Treatment of Opiate AddictionJAMA, 1998
- Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosingDrug and Alcohol Dependence, 1995
- A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependenceDrug and Alcohol Dependence, 1995
- Clinic Policy and Retention in Methadone MaintenanceInternational Journal of the Addictions, 1993
- The fifth edition of the addiction severity indexJournal of Substance Abuse Treatment, 1992
- Mortality in heroin addiction: impact of methadone treatmentActa Psychiatrica Scandinavica, 1990
- Relapse Prevention: Introduction and Overview of the ModelBritish Journal of Addiction, 1984
- The Swedish methadone maintenance program: A controlled studyDrug and Alcohol Dependence, 1981